The clinical research of 5% and 25% human serum albumin (ALB) in postoperative recovery of patients after liver resection or pancreatic operation

邓侠兴,沈柏用,吕文杰,詹茜,彭承宏,李宏为
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2009.03.012
2009-01-01
Abstract:Objective To assess the effect and security of Baxter 5% and 25% human serum al-bumin (ALB) in postoperative recovery of patients after liver resection or pancreatic operation.Methods 40 patients undergoing pancreatic operation and 60 patients undergoing hepatectomy in our hospital from January to October in 2007 were randomized into two groups: group A, the treatment group, including the patients who were given Baxter 5% or 25% ALB daily in operation day and 9 consecutive postoperative days, and group B, the control group ,including the patients who only re-ceived normal saline. The patients in group A were also randomized into two groups :group Al,inclu-ding the patients who were only given Baxter 5% ALB daily in operation day and 9 consecutive postop-erative days, and group B, including the patients who were given Baxter 5% ALB daily in operation day and 5 consecutive postoperative days and Baxter 25% ALB daily from 6th to 9th postoperative day. Comparisons were made postoperatively between the two groups with regard to related biochemi-cal tests of liver function ,serum electrolytes and coagulating indicies, as well as clinical variables in-cluding pancreatic or bile leak, ascites, pleural effusion, wound healing and in-hospital duration.Results Compared with group B, group A had higher level of albumin in serum and significantly shor-ter PT and APTT after liver resection following the treatment of ALB. Lower incidence of bile or pan-creatic leak after pancreatic operation was observed in group A. Moreover,the prevalence and magni-tude of postoperative ascites, pleural effusion were significantly decreased in group A and lower inci-dence in A1. Undesirable wound healing and in-hospital duration were also significantly decreasesd in group A. Conclusion As for patients undergoing liver resection or pancreatic operation, the use of ALB can markedly accelerate the restoration of liver and coagulating function reduce postoperative complication, promote wound healing and shorten in-hospital duration. 5% AI.B can be used to resolve hypoalbuminemia in operation day and early postoperative days. 25% ALB can be used to reduce ede-ma, ascites and pleural effusion remarkably in late postoperative day. Our research showed rational use of isotonic and hyperosmotic ALB solution on patients after liver or pancreatic operation can great-ly improve the liquid therapy and obtain greater clinical effect besides resolve hypoalbuminemia.
What problem does this paper attempt to address?